2nd Edition of International Conference on Tissue Engineering and Regenerative Medicine

September 16-17, 2022 | Paris, France

September 16 -17, 2022 | Paris, France


  • Cancer Immunotherapy
  • T-cell Immunotherapy
  • Xenogeneic Antigens
  • Tissue-Protective Technologies

Immunotherapy or biological therapy is that the treatment of disease by activating or suppressing the system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies. Cancer may be a complex disease which will evade and outsmart the system . It’s often not recognized until it's already become too difficult to handle.

Types of immunotherapies

  • Immune checkpoint therapy helps cancer-fighting immune cells, called T cells, mount a longer-lasting response against the cancer.
  • Adoptive cellular therapy increases the amount and/or effectiveness of immune cells, usually T cells, which improves the facility of the immune reaction against the cancer. There are three main sorts of adoptive cellular therapy.
  • Cytokine therapy relies on proteins called interferons and interleukins to trigger an immune reaction . Interleukin-2 (IL-2) is employed to treat kidney cancers and melanomas that have spread to other regions of the body. Interferon alpha (IFN-alpha) is currently being used to treat melanoma, kidney cancer and certain leukemia and lymphomas. These cytokine treatments also are being combined with other sorts of immunotherapies to extend their effectiveness.

Submit your abstract Today